HealthQuad, the healthcare-focused venture capital platform backed by Quadria Group, has announced the first close of its third investment fund, HealthQuad Fund III, raising Rs 550 crore, which represents more than one-third of its target corpus of Rs 1,700 crore.
Key Highlights
- HealthQuad secures Rs 550 crore commitments in first close of its Rs 1,700 crore healthcare fund.
- Fund III backs healthtech innovation with Lifesigns becoming its first portfolio investment company.
The latest fund received commitments from a mix of existing limited partners (LPs) from previous HealthQuad funds as well as new domestic and international investors, including fund-of-funds, institutional investors, and family offices. The firm has also completed its first investment from the new fund in Lifesigns, an AI-powered remote patient monitoring platform, while actively evaluating additional investment opportunities across the healthcare ecosystem.
Fund III to Back Next-Generation Healthcare Startups
HealthQuad Fund III succeeds the firm's earlier investment vehicles, Fund I and Fund II, and will focus on supporting early-growth-stage startups operating in high-potential healthcare segments, including healthtech, medtech, biopharma technology, and healthcare delivery.
The fund is managed by HealthQuad Advisors, a wholly owned subsidiary of Quadria Group, led by investment professionals Amit Varma, Abrar Mir, and Sunil Thakur.
According to the firm, these focus sectors are expected to contribute more than 40% of India’s projected $600 billion healthcare market by 2030, creating significant opportunities for technology-driven healthcare innovation.
Also Read: Indian Startup Funding Jumps 53% to $253 Million in the Latest Week
Lifesigns Becomes Fund III’s First Investment
Marking the deployment of capital from the new fund, HealthQuad has invested in Lifesigns, a healthcare technology company specializing in AI-driven remote patient monitoring solutions.
The investment reflects the firm's continued emphasis on digital healthcare innovations aimed at improving patient outcomes, increasing operational efficiency, and expanding access to quality care.
Building on a Strong Healthcare Investment Track Record
Founded in 2016, HealthQuad has established itself as a prominent healthcare-focused investor in India. Through its first two funds, the firm has backed more than 18 healthcare and life sciences companies, including notable names such as Qure.ai, Redcliffe Labs, CureSkin, Strand Life Sciences, Medikabazaar, Wysa, and ekincare.
Following its separation from KOIS in 2025, Quadria Group retained the majority of the investment team managing HealthQuad’s earlier funds and further strengthened its leadership with the addition of Rahul Agarwal and Namit Chugh.
Focus on Access Affordable and Technology-Led Care
HealthQuad said Fund III will continue investing in startups focused on improving healthcare access, affordability, and quality through technology innovation, scalable business models, and advanced healthcare products.
With healthcare demand rising rapidly and digital adoption accelerating across India, the new fund is expected to play a key role in supporting the next generation of healthcare entrepreneurs building solutions for the country's evolving healthcare needs.
